The efficacy and safety of KRD and KD regimens for multiple myeloma patients:Retrospective study by Kansai Myeloma Forum

The efficacy and safety of KRD and KD regimens for multiple myeloma patients:Retrospective study by Kansai Myeloma Forum - The efficacy and safety of KRD and KD regimens for MM patients:Retrospective study by KMF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037431

Enrollment

162

Registered

2019-08-01

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Relapsed/refractory multiple myeloma patients who were registered in the KMF database and received KRD or KD therapy

Exclusion criteria

Exclusion criteria: Patients who disagree to study participation

Design outcomes

Primary

Measure	Time frame
Progression free survival	—

Secondary

Measure	Time frame
Overall survival, Overall response rate, Adverse event	—

Countries

Japan

Contacts

Public ContactJunya Kanda

Graduate School of Medicine, Kyoto University Department of Hematology and Oncology

jkanda16@kuhp.kyoto-u.ac.jp075-751-3152

Outcome results